Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(03): 362-364
DOI: 10.1055/s-0042-1742635
Case Report

Neonatal Meningitis with Septicemia by Elizabethkingia meningoseptica: A Case Report

Neetha S. Murthy
1   Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India
,
Sowmya G. Shivappa
1   Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India
,
A. Tejashree
1   Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India
,
Krishna M.V.S. Karthik
1   Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India
,
R. Deepashree
1   Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India
› Author Affiliations Funding No separate funding was received apart from using laboratory facilities as part of the routine laboratory support from JSS medical college.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Elizabethkingia is ubiquitary aerobic bacillus abundantly found in the community as well as hospital environments. Elizabethkingia meningoseptica is an emerging nosocomial pathogen with an elemental ability to acclimate and survive in diversified environmental circumstances. Prompt diagnosis and an early therapeutic intervention are preponderant in the management of these infections. We report a case of meningitis with septicemia caused by E. meningoseptica in a 1-day-old outborn neonate. The child was stabilized with anticonvulsants and, based on laboratory findings, the neonate was started on ciprofloxacin in addition to symptomatic management. The child responded well to the treatment and was discharged on day 7 after treatment initiation. Perceptive treatment protocols backed with accurate laboratory evidence remain instrumental to avert unpropitious outcomes while combatting rare multidrug-resistant opportunistic infections.

Keywords

septicemia - Elizabethkingia meningoseptica - meningitis - multidrug resistant - neonate


Publication History

Article published online:
09 February 2022

© 2022. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Long SS. Principles and Practice of Pediatric Infectious Diseases. Fourth edition;. 2012: 1547-1712
    Google Scholar
  • 2 Kim KK, Kim MK, Lim JH, Park HY, Lee S-T. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol 2005; 55 (Pt 3): 1287-1293
    CrossrefPubMedGoogle Scholar
  • 3 Matyi SA, Hoyt PR, Hosoyama A, Yamazoe A, Fujita N, Gustafson JE. Draft genome sequences of Elizabethkingia meningoseptica. Genome Announc 2013; 1 (04) e00444-e13
    CrossrefPubMedGoogle Scholar
  • 4 Chen S, Soehnlen M, Downes FP, Walker ED. Insights from the draft genome into the pathogenicity of a clinical isolate of Elizabethkingia meningoseptica Em3. Stand Genomic Sci 2017; 12: 56
    CrossrefPubMedGoogle Scholar
  • 5 Bhat KS, Priya R, Krishnan L, Kanungo R. Elizabethkingia meningoseptica bacteremia in a neonate: a case report and mini-review of the literature. J Curr Res Sci Med 2016; 2: 42-45
    CrossrefGoogle Scholar
  • 6 Amer MZ, Bandey M, Bukhari A, Nemenqani D. Neonatal meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia. J Infect Dev Ctries 2011; 5 (10) 745-747
    CrossrefPubMedGoogle Scholar
  • 7 Rastogi N, Mathur P, Bindra A. et al. Infections due to Elizabethkingia meningoseptica in critically injured trauma patients: a seven-year study. J Hosp Infect 2016; 92 (01) 30-32
    CrossrefPubMedGoogle Scholar
  • 8 Kellogg JA, Manzella JP, Bankert DA. Frequency of low-level bacteremia in children from birth to fifteen years of age. J Clin Microbiol 2000; 38 (06) 2181-2185
    CrossrefPubMedGoogle Scholar
  • 9 Lin YT, Chiu CH, Chan YJ. et al. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis 2009; 41 (09) 628-634
    CrossrefPubMedGoogle Scholar
  • 10 Steinberg JP, Burd EM. Other gram negative and gram variable bacilli. In: Mandell GL, Bennett JE. and Dolin R. eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Seventh edition.. United States: Churchill Livingstone; 2010: 3015-3033
    Google Scholar
  • 11 Chen S, Soehnlen M, Blom J, Terrapon N, Henrissat B. et al. Comparative genomic analyses reveal diverse virulence factors and antimicrobial resistance mechanisms in clinical Elizabethkingia meningoseptica strains. PLOS ONE 2019; 14 (10) e0222648
    CrossrefPubMedGoogle Scholar
  • 12 Jacobs A, Chenia HY. Biofilm formation and adherence characteristics of an Elizabethkingia meningoseptica isolate from Oreochromis mossambicus. Ann Clin Microbiol Antimicrob 2011; 10: 16
    CrossrefPubMedGoogle Scholar
  • 13 Lau SKP, Chow W-N, Foo C-H. et al. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Sci Rep 2016; 6: 26045
    CrossrefPubMedGoogle Scholar
  • 14 Lin J-N, Lai C-H, Yang C-H, Huang Y-H, Lin H-F, Lin H-H. Comparison of four automated microbiology systems with 16S rRNA gene sequencing for identification of Chryseobacterium and Elizabethkingia species. Sci Rep 2017; 7 (01) 13824
    CrossrefPubMedGoogle Scholar
  • 15 Huang YC, Lin YT, Wang FD. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia. Int J Antimicrob Agents 2018; 51 (01) 47-51
    CrossrefPubMedGoogle Scholar
  • 16 Vincent JL, Bassetti M, François B. et al. Advances in antibiotic therapy in the critically ill. Crit Care 2016; 20 (01) 133
    CrossrefPubMedGoogle Scholar